James K. Hammitt

James K. Hammitt, “Consistent Valuation of a Reduction in Mortality Risk using Values per Life, Life Year, and Quality-Adjusted Life Year”, Health Economics, vol. 32, n. 9, September 2023, pp. 1964–1981.

James K. Hammitt, and Tuba Tuncel, “Monetary values of increasing life expectancy: sensitivity to shifts of the survival curve”, Journal of Risk and Uncertainty, May 2023.

James K. Hammitt, Jin-Tan Liu, and Jin-Long Liu, “Is survival a luxury good? Income elasticity of the value per statistical life”, Journal of Risk and Uncertainty, vol. 65, December 2022, p. 239–260.

James K. Hammitt, “Downside risk aversion vs decreasing absolute risk aversion: an intuitive exposition”, Theory and Decision, n. 71, October 2022.

Ankur Pandya, Mike Paulden, Jinyi Zhu, Tara A. Lavelle, and James K. Hammitt, “Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount Rates”, Medical Decision Making, vol. 42, n. 7, October 2022, pp. 885–892.

James K. Hammitt, and Seung Kyum Kim, “Hurricane risk perceptions and housing market responses: the pricing effects of risk-perception factors and hurricane characteristics”, Natural Hazards, n. 114, August 2022, p. 3743–3761.

James K. Hammitt, “Prevention, treatment, and palliative care: The relative value of health improvements under alternative evaluation frameworks”, Journal of Health Economics, vol. 84, n. 102643, July 2022.

Daniel Herrera-Araujo, Christoph Rheinberger, and James K. Hammitt, “Valuing non-marginal changes in mortality and morbidity risk”, Journal of Health Economics, vol. 84, n. 102627, July 2022.

Lisa A. Robinson, Michael Eber, and James K. Hammitt, “Valuing COVID-19 Morbidity Risk Reductions”, Journal of Benefit-Cost Analysis, vol. 13, n. 2, June 2022, pp. 247–268.

James K. Hammitt, and Nicolas Treich, “Prioritarianism and Fatality Risk Regulation”, in Prioritarianism in Practice, Matthew Adler, and Ole F. Norheim (eds.), Cambridge University Press, chapter 7, 2022, pp. 317 – 359.

James K. Hammitt, “Accounting for the Distribution of Benefits and Costs in Benefit–Cost Analysis”, Journal of Benefit-Cost Analysis, vol. 12, n. 1, April 2021, pp. 64 – 84.

Michael Eber, Cass Sunstein, James K. Hammitt, and Jennifer Yeh, “The Modest Effects of Fact Boxes on Cancer Screening”, Journal of Risk and Uncertainty, vol. 62, n. 8, February 2021, pp. 1–26.

Matthew Adler, Maddalena Ferranna, James K. Hammitt, and Nicolas Treich, “Fair Innings? The Utilitarian and Prioritarian Value of Risk Reduction over a Whole Lifetime”, Journal of Health Economics, vol. 75, n. 102412, January 2021.

James K. Hammitt, “Valuing mortality risk in the time of COVID-19”, Journal of Risk and Uncertainty, vol. 61, December 2020, pp. 129–154.

Meng-Wen Tsou, Jin-Tan Liu, James K. Hammitt, Chyi-Horng Lu, and Szu-Yu Zoe Kao, “The Effect of Prenatal Exposure to Radiation on Birth Outcomes: Exploiting a Natural Experiment in Taiwan”, Japanese Economic Review, vol. 71, n. 3, July 2020, pp. 379 – 403.

James K. Hammitt, P. Morfeld, J.T Tuomisto, and T.C Erren, “Premature Deaths and Statistical Lives: Identification, Quantification, and Valuation of Mortality Risks”, Risk Analysis, vol. 40, n. 4, April 2020, pp. 674–695.

Lisa A. Robinson, William Raich, James K. Hammitt, and L. O’Keeffe, “Valuing Children’s Fatality Risk Reductions”, Journal of Benefit-Cost Analysis, vol. 10, n. 2, July 2019, pp. 156–177.

Lisa A. Robinson, James K. Hammitt, and L. O’Keeffe, “Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis”, Journal of Benefit-Cost Analysis, vol. 10, July 2019, pp. 15–50.

James K. Hammitt, Fangli Geng, Xiaoqi Guo, and Chris P. Nielsen, “Valuing Mortality Risk in China: Comparing Stated-Preference Estimates from 2005 and 2016”, Journal of Risk and Uncertainty, vol. 58, n. 2, June 2019, pp. 167–186.

James K. Hammitt, B.R Murray, A. Kratka, K.A. Scherr, N. Eyal, J. Blumenthal-Barby, K. Freedberg, D.R. Kuritzkes, R. Edifor, M.N. Katz, K. Pollak, B.J. Zikmund-Fisher, S.D Halpern, M.C. Barks, and P.A. Ubel, “What Risk of Death Would People Take to be Cured of HIV, and Why? A Survey of People Living With HIV”, Journal of Virus Eradication, n. 5, April 2019, pp. 109–115.